Synthesis, radiosynthesis, and biological evaluation of fluorinated thienylcyclohexyl piperidine derivatives as potential radiotracers for the NMDA receptor-linked calcium ionophore

Nuclear Medicine and Biology

Volumn 23, Issue 3, 1996, Pages 315-324

  Ouyang, Xiaohu ^a   Mukherjee, Jogeshwar ^a   Yang, Zhi Ying ^a  

^a Franklin McLean Memorial Research Institute   (United States)

Author keywords

fluorine 18; NMDA receptor; PET; TCP

Indexed keywords

DIZOCILPINE; FLUORINE 18; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; THIENYLCYCLOHEXYLPIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MONKEY; POSITRON EMISSION TOMOGRAPHY; RAT;

EID: 0029992259     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02086-1     Document Type: Article

References (58)

1. Albers G. W., Goldberg M. P. and Choi D. W. (1989) N-methyl-D-aspartate antagonists: Ready for clinical trials in brain ischaemia? Ann. Neurol. 25, 398-403.
2. 18F]methyl-MK-801, a potential NMDA receptor complex radioligand. Neurosci Lett. 121, 183-186.
3. 3H]-MK-801 binding sites in mammalian brain. Br. J. Pharmacol. 93, 944-954.
4. 18F]fluoro-analogs of MK-801. Appl. Radiat. Isot. 40, 325-328.
5. Burns H. D., Eng W.-S., Dannals R. F., Wong D. F., Guilarte T. R., Wilson A. A., Ravert H. T., Gibson R. E., Britcher S. F., Frost J. J., Wagner H. N. and Solomon H. F. (1989) Design, synthesis and preliminary evaluation of (+)-[C-11]-8-methoxy-MK-801: A potential radiotracer for NMDA receptor imaging via PET. J. Nucl. Med. 30 (abstract), 930-921.
6. Casalotti S. O., Kozikowski A. P., Fauq A., Tuckmantel W. and Krueger K. E. (1992) Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors. J. Pharmacol. Exp. Ther. 260, 21-28.
7. 3H](thienyl-2)-1-cyclohexylpiperidine (TCP) dans le systeme nerveux central de rat. Eur. J. Med. Chem. 22, 359-362.
8. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
9. Collingridge G. L. and Gliss T. V. (1995) Memories of NMDA receptors and LTP. Trends Neurosci. 18, 54-56.
10. Cone E. J., McQuinn R. L. and Shannon H. E. (1984) Structure-activity relationship studies of phencyclidine derivatives in rats. J. Pharmacol. Exp. Ther. 228, 147-153.
11. 18F-2-fluoro-2-deoxy-D-glucose. Appl. Radiat. Isot. 37, 397-401.
12. 18F]-5(β-fluoroethyl)-10,11-dihydro-5H-dibenzocycloheptene-5, 10-imine. J. Labeled Cmpd. Radiopharm. 27, 1007-1013.
13. Dingledine R., McBain C. J. and McNamara J. O. (1990) Excitatory amino acids receptors in epilepsy. Trends Pharmacol. Sci. 11, 334-338.
14. Ferrarese C., Guidotti A., Costa E., Miletich R. S., Rice K. C., de Costa B. R., Fulham M. J. and Di Chiro G. (1991) In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexyl-piperidine, a possible ligand for positron emission tomography. Neuropharmacology 30, 899-905.
15. Frost J. J. and Wagner H. N., Jr., Eds. (1990) Quantitative Imaging: Neuroreceptors, Neurotransmitters and Enzyme. Ravern Press, New York.
16. Geneste P., Herrmann P., Kamenka J. M. and Pons A. (1975) Nouvelle voie d'acces aux isomeres des phenyl-1 cyclohexylamines subsituttees au cyclohexane. Bull. Chim. Soc. Fr. 7, 1619-1626.
17. Hermans B., van Daele P., van de Westeringh C., van der Eycken C., Boey J. and Janssen P. A. J. (1965) 4-Substituted piperidines: II. Reaction of 1-benzyl-4-cyano-4-t-aminopiperidines with organometallic compounds. J. Med. Chem. 8, 851-855.
18. Jahr C. E. (1992) High possibility opening of NMDA receptor channels by L-glutamate. Science 255, 470-472.
19. Jasinski D. R., Shannon H. E., Cone E. J., Vaupel D. B., Risner M. E., McQuinn R. L., Su T.-P. and Pickworth W. B. (1981) Interdisciplinary studies on phencyclidine. In PCP (phencydidine) : Historical and Current Perspective (Edited by Domino E. F.) pp. 331-400. NPP Books, Ann Arbor, Mich.
20. Johnson R. L. and Koerner J. F. (1988) Excitatory amino acid neurotransmission. J. Med. Chem. 31, 2057-2066.
21. Kalir A., Maayani S., Rehavi M., Elkavets R., Pri-Bar I., Buchman O. and Sokolovsky M. (1978) Structure-activity relationships of some phencyclidine derivatives: In vivo studies in mice. Eur. J. Med. Chem. 13, 17-24.
22. 11C]-MK-801)]. Appl. Radiat. Isot. 41, 139-142.
23. 18F]-FTCP). J. Labeled Cmpd. Radiopharm. 27, 277-286.
24. 3H]-1-[1-(2-thienyl)cyclohexyl]-piperidine.J. Pharmacol. Exp. Ther. 238, 739-748.
25. Leeson P. D., Carling R. W., James K., Smith J. D., Moore K. W., Wong E. H. F. and Baker R. (1990). Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel. J. Med. Chem. 33, 1296-1305.
26. Maddox H. V., Godefroi E. F. and Parcell R. F. (1965) The synthesis of phencyclidine and other 1-arylcyclohexylamines. J. Med. Chem. 8, 230-235.
27. 18F]fluoromethyl-1-(2-thienyl)cyclohexyl]piperidine. Appl. Radiat. Isot. 42, 563-570.
28. Manallack D. T., Wong M. G., Costa M., Andrews P. R. and Beart P. M. (1988) Receptor site topographies for phencyclidine-like and drugs: Predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses. Mol. Pharmacol. 34, 863-879.
29. 3H-TCP-labeled receptors in rat brain. J. Neurosci. 8, 493-501.
30. McQuinn R. L., Cone E. J., Shannon H. E. and Su T.-P. (1981) Phencyclidine: I. Structure-activity relationships of the cycloalkyl ring of phencyclidine. J. Med. Chem. 24, 1429-1432.
31. Monn J. A. and Schoepp D. D. (1994) Recent progress in excitatory amino acid research. Ann. Rep. Med. Chem. 29, 53-64.
32. Mukherjee J., Murphy S. N., Hartwig W., Miller R. J. and Cooper M. D. (1988) N-(3-F-18 fluoropropyl)MK-801: A PET tracer for in vivo studies of N-methyl-D-aspartate receptors. J. Nucl. Med. 29(abstract), 932.
33. Munson P. J. and Rodbard D. (1980). LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
34. 18F]fluoroethyl)-2-thienyl]cyclohexyl}-piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. Nucl, Med. Biol. 20, 865-873.
35. 18F]fluoromethyl-TCP, a potential tool for PET study of the NMDA receptor channel complex. J. Labeled Cmpd. Radiopharm. 31, 955-960.
36. 3H-Labeled MK-801 binding to excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc. Natl. Acad. Sci. USA 84, 7744-7748.
37. Rosenmund C., Feltz A. and Westbrook G. L. (1995) Synaptic NMDA receptor channels have a low open probability. J. Neurosci. 15, 2788-2795.
38. Rottman S. M. and Olney J. W. (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci. 19, 299-302.
39. Schwarcz R. and Meldrum B. (1985) Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet ii, 140-143.
40. Shannon H. E. (1981) Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. J. Pharmacol. Exp. Ther. 216, 543-551.
41. Shannon H. E. and DeGregorio C. M. (1981) Effects of N-substituted analogs phencyclidine on avoidance behavior in the rat. J. Pharmacol. Exp. Ther. 218, 55-62.
42. Shannon H. E., McQuinn R. L., Vaupel B. and Cone E. J. (1983) Effects of cycloalkyl ring analogues of phencyclidine on behavior in rodents. J. Pharmacol. Exp. Ther. 224, 327-333.
43. Stone T. W. and Burton N. R. (1988) NMDA receptors and ligands in the vertebrate CNS. Prog. Neurobiol. 30, 333-368.
44. Ter-Pogossian M. M., Ficke D. C., Hood J. T., Yamamoto M. and Mullani N. A. (1982) PETT VI: A positron emission tomograph utilizing cesium fluoride scintillation detectors. J. Comput. Assist. Tomogr. 6, 125-133.
45. Thompson W. J., Anderson P. A., Britcher S. F., Lyle T. A., Thies J. E., Magill C. A., Varga S. L., Schwering J. E., Lyle P. A., Christy M. E., Evans B. E., Colton C. D., Holloway M. K., Springer J. P., Hirshfield J. M., Ball R. G., Amato J. S., Larson R. D., Wong E. H. F., Kemp J. A., Tricklebank M. D., Singh L., Oles R., Pristley T., Marshall G. R., Knight A. R., Middlemiss D. N., Woofruff G. N. and Iversen L. L. (1990). Synthesis and pharmacological evaluation of a series of dibenzo[a,d]-cycloalkenimines as N-methyl-D-aspartate antagonists. J. Med. Chem. 33, 789-808.
46. Thurkauf A., de Costa B. R., Kiesewetter D. O., Jacobsen, A. E. and Rice K. C. (1989) Synthesis of tritium-labeled 4-fluoro-1-[1-(2-thienyl)cyclohexyl]piperidine (3H-FTCP), a tool for autoradiographic study of phencyclidine binding site. J. Label. Compd. Radiopharm. 27, 653-659.
47. Thurkauf A., Hillery P., Mattson M., Jacobson A. E. and Rice K. C. (1988) Synthesis, pharmacological action, and receptor binding affinity of the enantiomeric 1-(1-phenyl-3-methylcyclohexyl)piperidines. J. Med. Chem. 31, 1625-1628.
48. Thurkauf A., de Costa B. R., Mattson M. V., France C. P., Price M. T., Olney J. W., Woods J. H. Jacobson A. E. and Rice K. C. (1990a) Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines. J. Med. Chem. 33, 2211-2215.
49. Thurkauf A., de Costa B., Yamaguchi S., Mattson M. V., Jacobson A. E., Rice K. C. and Rogawski M. A. (1990b) Synthesis and anticonvulsant activity of 1-phenylcyclohexyl amine analogues. J. Med. Chem. 33, 1452-1458.
50. Tricklebank M. D., Singh L., Oles R. J., Preston C. and Iverson S. D. (1989) The behavior effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127-135.
51. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-418.
52. 18F-PCP analogs for positron emission tomography (PET). J. Nucl. Med. 29 (abstract), 767-768.
53. Vaupel D. B., McCoun D. and Cone E. J. (1984) Phencyclidine analogues and precursors: Rotarod and lethal dose studies in the mouse. J. Pharmacol. Exp. Ther. 230, 20-27.
54. Wachtel H. and Turski L. (1990) L-glutamate: a new target in schizophrenia. Trends Pharmacol Sci. 11, 219-220.
55. Wieland D. M., Kilbourn M. R., Yang D. J., Laborde E., Gildersleeve D. L., Van Dort M. E., Pirat J.-L., Ciliax B. J. and Young A. B. (1988) NMDA receptor channels: Labeling of MK-801 with iodine-125 and fluorine-18. Appl. Radiat. Isot. 39, 1219-1225.
56. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50, 274-281.
57. Young A. B. and Fagg G. E. (1990) Excitatory amino acid receptors in the brain: Membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11, 126-133.
58. Zenone F. and Kamenka J. M. (1991) Conformational adaptation to surroundings of PCP, TCP and BTCP molecules: A tentative explanation for different biochemical specificities. Eur. J. Med. Chem. 26, 677-686.